AnaptysBio, Inc. (ANAB)
45.78
+0.83
(+1.85%)
USD |
NASDAQ |
Dec 11, 16:00
45.70
-0.08
(-0.17%)
After-Hours: 07:40
AnaptysBio Research and Development Expense (TTM): 152.43M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ovid Therapeutics, Inc. | 24.66M |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| Vanda Pharmaceuticals, Inc. | 100.10M |
| CorMedix, Inc. | 12.46M |
| Verastem, Inc. | 103.74M |